Copyright Reports & Markets. All rights reserved.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Loop-mediated Isothermal Amplification
    • 1.2.3 Nucleic Acid Sequence-based Amplification
    • 1.2.4 Rolling Circle Amplification
    • 1.2.5 Single Primer Isothermal Amplification
    • 1.2.6 Helicase-dependent Isothermal DNA Amplification
    • 1.2.7 Recombinase Polymerase Amplification
    • 1.2.8 Strand Displacement Amplification
  • 1.3 Market by Application
    • 1.3.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application: 2020 VS 2026
    • 1.3.2 Infectious Disease Diagnosis
    • 1.3.3 Blood Screening
    • 1.3.4 Cancer Diagnosis
    • 1.3.5 Cancer Research and Laboratory Research
    • 1.3.6 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Perspective (2015-2026)
  • 2.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Growth Trends by Regions
    • 2.2.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Market Size
    • 3.1.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Revenue (2015-2020)
    • 3.1.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Players (2015-2020)
  • 3.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue
  • 3.4 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio
    • 3.4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2019
  • 3.5 Key Players Isothermal Nucleic Acid Amplification Technology (INAAT) Area Served
  • 3.6 Key Players Isothermal Nucleic Acid Amplification Technology (INAAT) Product Solution and Service
  • 3.7 Date of Enter into Isothermal Nucleic Acid Amplification Technology (INAAT) Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Type (2015-2026)

  • 4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Type (2015-2020)
  • 4.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Type (2021-2026)

5 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Application (2015-2026)

  • 5.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Application (2015-2020)
  • 5.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2015-2026)
  • 6.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2015-2020)
  • 6.3 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2015-2020)
  • 6.4 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2015-2026)
  • 7.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2015-2020)
  • 7.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2015-2020)
  • 7.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2015-2026)
  • 8.2 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2015-2020)
  • 8.3 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2015-2020)
  • 8.4 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2015-2026)
  • 9.2 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2015-2020)
  • 9.3 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2015-2020)
  • 9.4 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2015-2026)
  • 10.2 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Grifols
    • 11.1.1 Grifols Company Details
    • 11.1.2 Grifols Business Overview
    • 11.1.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 11.1.4 Grifols Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020))
    • 11.1.5 Grifols Recent Development
  • 11.2 Hologic
    • 11.2.1 Hologic Company Details
    • 11.2.2 Hologic Business Overview
    • 11.2.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 11.2.4 Hologic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 11.2.5 Hologic Recent Development
  • 11.3 Abbott Laboratories
    • 11.3.1 Abbott Laboratories Company Details
    • 11.3.2 Abbott Laboratories Business Overview
    • 11.3.3 Abbott Laboratories Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 11.3.4 Abbott Laboratories Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 11.3.5 Abbott Laboratories Recent Development
  • 11.4 BD
    • 11.4.1 BD Company Details
    • 11.4.2 BD Business Overview
    • 11.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 11.4.4 BD Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 11.4.5 BD Recent Development
  • 11.5 Meridian Bioscience
    • 11.5.1 Meridian Bioscience Company Details
    • 11.5.2 Meridian Bioscience Business Overview
    • 11.5.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 11.5.4 Meridian Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 11.5.5 Meridian Bioscience Recent Development
  • 11.6 Eiken Chemical
    • 11.6.1 Eiken Chemical Company Details
    • 11.6.2 Eiken Chemical Business Overview
    • 11.6.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 11.6.4 Eiken Chemical Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 11.6.5 Eiken Chemical Recent Development
  • 11.7 Quidel Corporation
    • 11.7.1 Quidel Corporation Company Details
    • 11.7.2 Quidel Corporation Business Overview
    • 11.7.3 Quidel Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 11.7.4 Quidel Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 11.7.5 Quidel Corporation Recent Development
  • 11.8 QIAGEN
    • 11.8.1 QIAGEN Company Details
    • 11.8.2 QIAGEN Business Overview
    • 11.8.3 QIAGEN Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 11.8.4 QIAGEN Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 11.8.5 QIAGEN Recent Development
  • 11.9 bioMerieux
    • 11.9.1 bioMerieux Company Details
    • 11.9.2 bioMerieux Business Overview
    • 11.9.3 bioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 11.9.4 bioMerieux Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 11.9.5 bioMerieux Recent Development
  • 11.10 Tecan
    • 11.10.1 Tecan Company Details
    • 11.10.2 Tecan Business Overview
    • 11.10.3 Tecan Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 11.10.4 Tecan Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 11.10.5 Tecan Recent Development
  • 11.11 DiaSorin
    • 10.11.1 DiaSorin Company Details
    • 10.11.2 DiaSorin Business Overview
    • 10.11.3 DiaSorin Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.11.4 DiaSorin Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.11.5 DiaSorin Recent Development
  • 11.12 Thermo Fisher Scientific
    • 10.12.1 Thermo Fisher Scientific Company Details
    • 10.12.2 Thermo Fisher Scientific Business Overview
    • 10.12.3 Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.12.4 Thermo Fisher Scientific Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.12.5 Thermo Fisher Scientific Recent Development
  • 11.13 Illumina
    • 10.13.1 Illumina Company Details
    • 10.13.2 Illumina Business Overview
    • 10.13.3 Illumina Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.13.4 Illumina Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.13.5 Illumina Recent Development
  • 11.14 New England Biolabs
    • 10.14.1 New England Biolabs Company Details
    • 10.14.2 New England Biolabs Business Overview
    • 10.14.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.14.4 New England Biolabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.14.5 New England Biolabs Recent Development
  • 11.15 TwistDx
    • 10.15.1 TwistDx Company Details
    • 10.15.2 TwistDx Business Overview
    • 10.15.3 TwistDx Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.15.4 TwistDx Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.15.5 TwistDx Recent Development
  • 11.16 Mast Group
    • 10.16.1 Mast Group Company Details
    • 10.16.2 Mast Group Business Overview
    • 10.16.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.16.4 Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.16.5 Mast Group Recent Development
  • 11.17 Lucigen Corporation
    • 10.17.1 Lucigen Corporation Company Details
    • 10.17.2 Lucigen Corporation Business Overview
    • 10.17.3 Lucigen Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.17.4 Lucigen Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.17.5 Lucigen Corporation Recent Development
  • 11.18 Ustar Biotechnologies
    • 10.18.1 Ustar Biotechnologies Company Details
    • 10.18.2 Ustar Biotechnologies Business Overview
    • 10.18.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.18.4 Ustar Biotechnologies Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.18.5 Ustar Biotechnologies Recent Development
  • 11.19 Genomtec
    • 10.19.1 Genomtec Company Details
    • 10.19.2 Genomtec Business Overview
    • 10.19.3 Genomtec Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.19.4 Genomtec Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.19.5 Genomtec Recent Development
  • 11.20 Jena Bioscience
    • 10.20.1 Jena Bioscience Company Details
    • 10.20.2 Jena Bioscience Business Overview
    • 10.20.3 Jena Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.20.4 Jena Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.20.5 Jena Bioscience Recent Development
  • 11.21 OptiGene
    • 10.21.1 OptiGene Company Details
    • 10.21.2 OptiGene Business Overview
    • 10.21.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.21.4 OptiGene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.21.5 OptiGene Recent Development
  • 11.22 Sysmex Corporation
    • 10.22.1 Sysmex Corporation Company Details
    • 10.22.2 Sysmex Corporation Business Overview
    • 10.22.3 Sysmex Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.22.4 Sysmex Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.22.5 Sysmex Corporation Recent Development
  • 11.23 Premier Biosoft
    • 10.23.1 Premier Biosoft Company Details
    • 10.23.2 Premier Biosoft Business Overview
    • 10.23.3 Premier Biosoft Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.23.4 Premier Biosoft Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.23.5 Premier Biosoft Recent Development
  • 11.24 mFluiDx
    • 10.24.1 mFluiDx Company Details
    • 10.24.2 mFluiDx Business Overview
    • 10.24.3 mFluiDx Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.24.4 mFluiDx Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.24.5 mFluiDx Recent Development
  • 11.25 Cangene
    • 10.25.1 Cangene Company Details
    • 10.25.2 Cangene Business Overview
    • 10.25.3 Cangene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
    • 10.25.4 Cangene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
    • 10.25.5 Cangene Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Isothermal Nucleic Acid Amplification Technology (INAAT) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Isothermal Nucleic Acid Amplification Technology (INAAT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    by Technology
    Loop-mediated Isothermal Amplification
    Nucleic Acid Sequence-based Amplification
    Rolling Circle Amplification
    Single Primer Isothermal Amplification
    Helicase-dependent Isothermal DNA Amplification
    Recombinase Polymerase Amplification
    Strand Displacement Amplification
    by Product Type
    Assay
    Kits
    Reagents

    Market segment by Application, split into
    Infectious Disease Diagnosis
    Blood Screening
    Cancer Diagnosis
    Cancer Research and Laboratory Research
    Other

    Based on regional and country-level analysis, the Isothermal Nucleic Acid Amplification Technology (INAAT) market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Isothermal Nucleic Acid Amplification Technology (INAAT) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Grifols
    Hologic
    Abbott Laboratories
    BD
    Meridian Bioscience
    Eiken Chemical
    Quidel Corporation
    QIAGEN
    bioMerieux
    Tecan
    DiaSorin
    Thermo Fisher Scientific
    Illumina
    New England Biolabs
    TwistDx
    Mast Group
    Lucigen Corporation
    Ustar Biotechnologies
    Genomtec
    Jena Bioscience
    OptiGene
    Sysmex Corporation
    Premier Biosoft
    mFluiDx
    Buy now